Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tradeindia Cancer, Tb & Tumor Drugs Anti Cancer Injection Price: 3580.00 INR / Box (3580.00 INR + 0% GST) Get Latest Price In Stock Product Specifications Product Overview Key Features Triple-Action Receptor Agonist (GIP/GLP-1/Glucagon) High-Potency 40mg Formulation Advanced Metabolic Rate Stimulation Targeted Appetite & Craving Control Enhanced Multi-Pathway Lipolysis Convenient Once-Weekly Subcutaneous Dosing Optimized Glycemic & Insulin Support High-Purity Sterile Injectable Solution Sustained Energy & Caloric Efficiency Targeted Weight & Body Composition Support Alluvi Retatrutide 20 mg is being marketed online as a form of retatrutide, an experimental peptide that activates GLP-1, GIP, and glucagon receptors
Comparative work with selective MC4R agonists (including bremelanotide, which was developed as a Melanotan-II-derived analog with improved MC4R selectivity) and selective MC3R agonists helps dissect the individual contributions of these receptor subtypes to integrated energy balance regulation
Just maybe going back to the drawing board and asking more detailed questions, I would assume
Digestive symptoms like nausea, vomiting, diarrhoea, and bloating are the most commonly reported side effects after dose changes
So this is not cheap
This will also prevent nausea associated with a dose increase
